Qian Mei
- Cancer Research top 2%
- MicroRNA in disease regulation 11
- Cancer-related molecular mechanisms research 9
- Immunology top 5%
- Immune Cell Function and Interaction 5
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 6
- Molecular Biology top 5%
- DNA Repair Mechanisms 11
- RNA modifications and cancer 7
- Molecular Medicine top 5%
-
- Bacterial Genetics and Biotechnology 7
-
- Lymphoma Diagnosis and Treatment 5
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Clinical Cancer Research (4 papers)Journal of Clinical Oncology (4 papers)PLoS ONE (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Qian Mei
64 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 888
- Immunology 827
- Oncology 792
- Molecular Biology 1.6k
- Molecular Medicine 77
Countries citing papers authored by Qian Mei
This map shows the geographic impact of Qian Mei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Mei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Mei more than expected).
Fields of papers citing papers by Qian Mei
This network shows the impact of papers produced by Qian Mei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Mei. The network helps show where Qian Mei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qian Mei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2023 | 10 | |
| 3 | 2023 | 17 | |
| 4 | 2023 | 31 | |
| 5 | 2021 | 29 | |
| 6 | 2021 | 14 | |
| 7 | 2021 | 160 | |
| 8 | 2020 | 89 | |
| 9 | CUL4A promotes the invasion of cervical cancer cells by regulating NF-κB signaling pathway | 2020 | 4 |
| 10 | 2020 | 17 | |
| 11 | 2019 | 124 | |
| 12 | 2018 | 5 | |
| 13 | 2017 | 45 | |
| 14 | 2016 | 30 | |
| 15 | 2015 | 46 | |
| 16 | 2015 | 32 | |
| 17 | 2013 | 43 | |
| 18 | 2012 | 61 | |
| 19 | 2009 | 256 | |
| 20 | 2006 | 18 |
About Qian Mei
Qian Mei is a scholar working on Cancer Research, Immunology and Oncology, having authored 68 papers that have together received 3.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (11 papers), MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (7 papers), Bacterial Genetics and Biotechnology (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (888 citations), Immunology (827 citations) and Oncology (792 citations). Qian Mei has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Weidong Han, Zhiqiang Wu, Meixia Chen, Jiejie Liu, Jing Nie, Xiaolei Li, Kaichao Feng, Xue Geng, Mingzhou Guo and Shuhan Sun. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, PLoS ONE, Current Protein and Peptide Science and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.